Cited by 472Lipoproteins and Cardiovascular HealthGenetic Associations and EpidemiologyLipid metabolism and disorders

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

Plasma lipoproteins: genetic influences and clinical implications

Hegele, Robert A.·2009·Nature Reviews Genetics

Open this paper in CoChat — free account

Abstract

Susceptibility to the growing global public health problem of cardiovascular disease is associated with levels of plasma lipids and lipoproteins. Several experimental strategies have helped us to clarify the genetic architecture of these complex traits, including classical studies of monogenic dyslipidaemias, resequencing, phenomic analysis and, more recently, genome-wide association studies and analysis of metabolic networks. The genetic basis of plasma lipoprotein levels can now be modelled as a mosaic of contributions from multiple DNA sequence variants, both rare and common, with varying effect sizes. In addition to filling gaps in our understanding of plasma lipoprotein metabolism, the recent genetic advances will improve our ability to classify, diagnose and treat dyslipidaemias.

Integrity signals

Registry

Crossref · 10.1038/nrg2481

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Global variation in copy number in the human genome
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,377
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC Transporters
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J. R., Kwiterovich, P. O., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,645
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386
Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
Cohen, J., Pertsemlidis, A., Kotowski, I. K., Graham, R., Garcia, C. K., & Hobbs, H. H. (2005) · Nature Genetics · doi:10.1038/ng1509 · Cited by 1,381
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364
On the allelic spectrum of human disease
Reich, D. E., & Lander, E. S. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02410-6 · Cited by 1,185
Genome-wide association studies: theoretical and practical concerns
Wang, W. Y. S., Barratt, B. J., Clayton, D. G., & Todd, J. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1522 · Cited by 1,183
Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol
Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., & Hobbs, H. H. (2004) · Science · doi:10.1126/science.1099870 · Cited by 1,108
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Dietary influences on serum lipids and lipoproteins.
Grundy, S. M., & Denke, M. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42625-2 · Cited by 1,044
Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis
Brasaemle, D. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700014-jlr200 · Cited by 997
Variations in DNA elucidate molecular networks that cause disease
Chen, Y., Zhu, J., Lum, P. Y., Yang, X., Pinto, S., MacNeil, D. J., Zhang, C., Lamb, J., Edwards, S., Sieberts, S. K., et al. (2008) · Nature · doi:10.1038/nature06757 · Cited by 887
Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome
Lass, A., Zimmermann, R., Haemmerle, G., Riederer, M., Schoiswohl, G., Schweiger, M., Kienesberger, P. C., Bogner‐Strauß, J. G., Gorkiewicz, G., & Zechner, R. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.03.005 · Cited by 884
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., Steyn, K., Sanderson, J. E., Hasani, M., Volkova, E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61076-4 · Cited by 864
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
Aulchenko, Y. S., Janssens, A. C. J. W., Albert Hofman, D., Isaacs, A. J., Sijbrands, E. J. G., Witteman, J. C. M., van Duijn, C. M., Ripatti, S., Lindqvist, I., Perola, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.269 · Cited by 860
Association of apolipoprotein E genotypes with lipid levels and coronary risk
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1300 · Cited by 794
The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis
Repa, J. J., & Mangelsdorf, D. J. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.459 · Cited by 762
Genome-wide association analysis of metabolic traits in a birth cohort from a founder population
Sabatti, C., Service, S. K., Hartikainen, A., Pouta, A. M., Ripatti, S., Brodsky, J. F., Jones, C. G., Zaitlen, N., Varilo, T., Kaakinen, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.271 · Cited by 732
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Kathiresan, S., Melander, O., Anevski, D., Guiducci, C., Burtt, N. P., Roos, C., Hirschhorn, J. N., Berglund, G., Hedblad, B., Groop, L., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706728 · Cited by 696
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Pollin, T. I., Damcott, C. M., Shen, H., Ott, S. H., Shelton, J., Horenstein, R. B., Post, W., McLenithan, J. C., Bielak, L. F., Peyser, P. A., et al. (2008) · Science · doi:10.1126/science.1161524 · Cited by 688
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption
Lee, M., Lu, K., Hazard, S., Yu, H., Shulenin, S., Hidaka, H., Kojima, H., Allikmets, R. L., SAKUMA, N., Pegoraro, R. J., et al. (2001) · Nature Genetics · doi:10.1038/83799 · Cited by 681
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Frank-Kamenetsky, M. D., Grefhorst, A., Anderson, N. N., Racie, T., Bramlage, B., Akinc, A., Butler, D., Charissé, K., Dorkin, J. R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 644
Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term Coronary, Cardiovascular, and All-Cause Mortality and to Longevity
Stamler, J. (2000) · JAMA · doi:10.1001/jama.284.3.311 · Cited by 609
Familial lipoprotein disorders in patients with premature coronary artery disease.
Genest, J. J., Martin-Munley, S., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 598
Most Rare Missense Alleles Are Deleterious in Humans: Implications for Complex Disease and Association Studies
Kryukov, G. V., Pennacchio, L. A., & Sunyaev, S. R. (2007) · The American Journal of Human Genetics · doi:10.1086/513473 · Cited by 598
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
Rader, D. J., Cohen, J. C., & Hobbs, H. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18925 · Cited by 565
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis
Uyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 538
Translating molecular discoveries into new therapies for atherosclerosis
Rader, D. J., & Daugherty, A. (2008) · Nature · doi:10.1038/nature06796 · Cited by 515
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL
Romeo, S., Pennacchio, L. A., Fu, Y., Boerwinkle, E., Tybjaerg-Hansen, A., Hobbs, H. H., & Cohen, J. C. (2007) · Nature Genetics · doi:10.1038/ng1984 · Cited by 511
Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes
Göring, H. H. H., Curran, J. E., Johnson, M. P., Dyer, T. D., Charlesworth, J., Cole, S. A., Jowett, J. B. M., Abraham, L. J., Rainwater, D. L., Comuzzie, A. G., et al. (2007) · Nature Genetics · doi:10.1038/ng2119 · Cited by 503
Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
Thompson, A. (2008) · JAMA · doi:10.1001/jama.299.23.2777 · Cited by 498
Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
Frikke-Schmidt, R. (2008) · JAMA · doi:10.1001/jama.299.21.2524 · Cited by 464
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
Rader, D. J., Cohen, J., & Hobbs, H. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318925 · Cited by 450
Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons
Beigneux, A. P., Davies, B. S. J., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F., Bunting, S., Walzem, R. L., Wong, J. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.02.002 · Cited by 445
Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia
Wallace, C., Newhouse, S., Braund, P. S., Zhang, F., Tobin, M. D., Falchi, M., Ahmadi, K. R., Dobson, R., Marçano, A. C. B., Hajat, C., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.001 · Cited by 441
Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism
Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427
Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?
Ebrahim, S., & Davey Smith, G. (2008) · Human Genetics · doi:10.1007/s00439-007-0448-6 · Cited by 410
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders
Jones, B., Jones, E. L., Bonney, S. A., Patel, H., Mensenkamp, A. R., Eichenbaum‐Voline, S., Rudling, M. J., Myrdal, U., Annesi, G., Naik, S., et al. (2003) · Nature Genetics · doi:10.1038/ng1145 · Cited by 384
Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels
Cohen, J. C., Pertsemlidis, A., Fahmi, S., Esmail, S., Vega, G. L., Grundy, S. M., & Hobbs, H. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508483103 · Cited by 380
APOUPOPROTEIN E ISOFORMS, SERUM CHOLESTEROL, AND CANCER
Katan, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92972-7 · Cited by 371
LDL-cholesterol concentrations: a genome-wide association study
Sandhu, M. S., Waterworth, D. M., Debenham, S. L., Wheeler, E., Papadakis, K., Zhao, J. H., Song, K. S., Yuan, X., Johnson, T., Ashford, S. E., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60208-1 · Cited by 351
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)
Pajukanta, P., Lilja, H. E., Sinsheimer, J. S., Cantor, R. M., Lusis, A. J., Gentile, M., Duan, X. J., Soro‐Paavonen, A., Naukkarinen, J., Saarela, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1320 · Cited by 347
ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase
Shimizugawa, T., Ono, M., Shimamura, M., Yoshida, K., Ando, Y., Koishi, R., Ueda, K., Inaba, T., Minekura, H., Kohama, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203215200 · Cited by 339
A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study
Kathiresan, S., Manning, A. K., Demissie, S., D’Agostino, R. B., Surti, A., Guiducci, C., Gianniny, L., Burtt, N. P., Melander, O., Orho‐Melander, M., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s17 · Cited by 338
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides
Kooner, J. S., Chambers, J. C., Aguilar-Salinas, C. A., Hinds, D. A., Hyde, C. L., Warnes, G. R., Pérez, F. J. G., Frazer, K. A., Elliott, P., Scott, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.61 · Cited by 335
Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase
Yoshida, K., Shimizugawa, T., Ono, M., & Furukawa, H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.c200010-jlr200 · Cited by 317
Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis
Wolfrum, C., Poy, M. N., & Stoffel, M. (2005) · Nature Medicine · doi:10.1038/nm1211 · Cited by 300
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study.
Austin, M. A., McKnight, B., Edwards, K. L., Bradley, C. M., McNeely, M. J., Psaty, B. M., Brunzell, J. D., & Motulsky, A. G. (2000) · Circulation · doi:10.1161/01.cir.101.24.2777 · Cited by 255
Lipid disorders and mutations in the APOB gene
Whitfield, A. J., Barrett, P. H. R., van Bockxmeer, F. M., & Burnett, J. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038026 · Cited by 243
VIRUS-INFECTION OF URINARY-TRACT
Brouwers, T. M., Fontein, D. L., & Value, N. (1974) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 236
Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia.
Péterfy, M., Ben-Zeev, O., Mao, H. Z., Weissglas-Volkov, D., Aouizerat, B. E., Pullinger, C. R., Frost, P. H., Kane, J. P., Malloy, M. J., Reue, K., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.24 · Cited by 226
Medical Sequencing at the Extremes of Human Body Mass
Ahituv, N., Kavaslar, N., Schackwitz, W., Ustaszewska, A., Martin, J., Hébert, S., Doelle, H., Ersoy, B. A., Kryukov, G. V., Schmidt, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513471 · Cited by 225
Genetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 219
Intramuscular Administration of AAV1-Lipoprotein Lipase S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients
Stroes, E. S., Nierman, M. C., Meulenberg, J. J., Franssen, R., Twisk, J., Henny, C. P., Maas, M. M., Zwinderman, A. H., Ross, C., Aronica, E., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.175620 · Cited by 209
Lowering LDL—not only how low, but how long?
Brown, M. S., & Goldstein, J. L. (2006) · Science · doi:10.1126/science.1125884 · Cited by 204
Molecular diagnosis of hypobetalipoproteinemia: An ENID review
Tarugi, P., Averna, M. R., Leo, E. D., Cefalu, A. B., Noto, D., Magnolo, L., Cattin, L., Bertolini, S., & Calandra, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.003 · Cited by 179
Disruption of cholesterol homeostasis by plant sterols
Yang, C., Yu, L., Li, W., Xu, F., Cohen, J. C., & Hobbs, H. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22186 · Cited by 171
Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk
van der Steeg, W. A., Boekholdt, S. M., Stein, E. A., El-Harchaoui, K., Stroes, E. S. G., Sandhu, M. S., Wareham, N. J., Jukema, J. W., Luben, R., Zwinderman, A. H., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00007 · Cited by 165
Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin
Medina, M. W., Gao, F., Ruan, W., Rotter, J. I., & Krauss, R. M. (2008) · Circulation · doi:10.1161/circulationaha.108.773267 · Cited by 144
Identification of Genetic Variants in Endothelial Lipase in Persons With Elevated High-Density Lipoprotein Cholesterol
deLemos, A. S., Wolfe, M. L., Long, C., Sivapackianathan, R., & Rader, D. J. (2002) · Circulation · doi:10.1161/01.cir.0000028423.07623.6a · Cited by 138
A thematic review series: systems biology approaches to metabolic and cardiovascular disorders
Lusis, A. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.e600004-jlr200 · Cited by 135
Polygenic determinants of severe hypertriglyceridemia
Wang, J., Ban, M. R., Zou, G., Cao, H., Lin, T., Kennedy, B. A., Anand, S., Yusuf, S., Huff, M. W., Pollex, R. L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn188 · Cited by 129
Self-citation
GENETICS OF LIPOPROTEIN ABNORMALITIES ASSOCIATED WITH CORONARY HEART DISEASE SUSCEPTIBILITY
Breslow, J. L. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.233 · Cited by 128
Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment
Simon, J. S., Karnoub, M., Devlin, D. J., Arreaza, M. G., Qiu, P., Monks, S. A., Severino, M. E., Deutsch, P., Palmisano, J. J., Sachs, A. B., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.007 · Cited by 126
Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C‐II
Fojo, S. S., & Brewer, H. B. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01256.x · Cited by 121
Inherited disorders of HDL metabolism and atherosclerosis
Hovingh, G. K., de Groot, E., van der Steeg, W. A., Boekholdt, S. M., Hutten, B. A., Kuivenhoven, J. A., & Kastelein, J. J. P. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162318.47172.ef · Cited by 115
A treasure trove for lipoprotein biology
Lusis, A. J., & Pajukanta, P. (2008) · Nature Genetics · doi:10.1038/ng0208-129 · Cited by 110
Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650)
Wang, J., Cao, H., Ban, M. R., Kennedy, B. A., Zhu, S., Anand, S. S., Yusuf, S., Pollex, R. L., & Hegele, R. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.150680 · Cited by 108
Self-citation
The rationale for using apoA‐I as a clinical marker of cardiovascular risk
Barter, P. J., & Rye, K.-A. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01647.x · Cited by 103
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
Steinberg, D. H., Glass, C. K., & Witztum, J. L. (2008) · Circulation · doi:10.1161/circulationaha.107.753152 · Cited by 102
Genetics of familial combined hyperlipidemia and risk of coronary heart disease
Shoulders, C. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh069 · Cited by 96
High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
Assmann, G., von Eckardstein, A., & Funke, H. (1993) · PubMed · Cited by 91
GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons
Young, S. G., Davies, B. S. J., Fong, L. G., Gin, P., Weinstein, M. M., Bensadoun, A., & Beigneux, A. P. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3281527914 · Cited by 87
Multiple Genetic Determinants of Variation of Plasma Lipoproteins in Alberta Hutterites
Hegele, R. A., Brunt, J., & Connelly, P. W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.861 · Cited by 81
Self-citation
From Darwin's Finches to Canaries in the Coal Mine — Mining the Genome for New Biology
Hunter, D. J., Altshuler, D., & Rader, D. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0804318 · Cited by 80
The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly
Incardona, J. P., & Roelink, H. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000653 · Cited by 76
An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients*
Pullinger, C. R., Aouizerat, B. E., Movsesyan, I., Durlach, V., Sijbrands, E. J. G., Nakajima, K., Poon, A., Dallinga‐Thie, G. M., Hattori, H., Green, L., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.p800011-jlr200 · Cited by 68
The value of HDL genetics
Holleboom, A. G., Vergeer, M., Hovingh, G. K., Kastelein, J. J. P., & Kuivenhoven, J. A. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328306a043 · Cited by 64
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm
Sniderman, A. D. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137220.39031.3b · Cited by 62
APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia
Wang, J., Ban, M. R., Kennedy, B. A., Anand, S. S., Yusuf, S., Huff, M. W., Pollex, R. L., & Hegele, R. A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1326 · Cited by 60
Self-citation
Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes
Fahmi, S., Yang, C., Esmail, S., Hobbs, H. H., & Cohen, J. C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn108 · Cited by 59
Promise of Low-Density Lipoprotein–Lowering Therapy for Primary and Secondary Prevention
Grundy, S. M. (2008) · Circulation · doi:10.1161/circulationaha.107.720300 · Cited by 56
WW-Domain-Containing Oxidoreductase Is Associated with Low Plasma HDL-C Levels
Lee, J. C., Weissglas‐Volkov, D., Kyttälä, M., Dastani, Z., Cantor, R. M., Sobel, E. M., Plaisier, C. L., Engert, J. C., van Greevenbroek, M. M. J., Kane, J. P., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.002 · Cited by 55
Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies
Ahnström, J., Axler, O., Jauhiainen, M., Salomaa, V. V., Havulinna, A. S., Ehnholm, C., Frikke‐Schmidt, R., Tybjærg‐Hansen, A., & Dahlbäck, B. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700471-jlr200 · Cited by 54
Naturally occurring mutations in mice affecting lipid transport and metabolism.
Reue, K., & Doolittle, M. H. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39126-4 · Cited by 53
Defining the spectrum of alleles that contribute to blood lipid concentrations in humans
Kathiresan, S., Musunuru, K., & Orho‐Melander, M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f70296 · Cited by 48
Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution
Gin, P., Beigneux, A. P., Davies, B. S. J., Young, M. F., Ryan, R. O., Bensadoun, A., Fong, L. G., & Young, S. G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.10.005 · Cited by 45
Rare APOA5 mutations—Clinical consequences, metabolic and functional effects
Talmud, P. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.010 · Cited by 42
Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative?
Humphries, S. E., Yiannakouris, N., & Talmud, P. J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f5283e · Cited by 40
Antisense apolipoprotein B therapy: where do we stand?
Akdim, F., Stroes, E. S. G., & Kastelein, J. J. P. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328248b4ad · Cited by 33
Genomic copy number variation and its potential role in lipoprotein and metabolic phenotypes
Pollex, R. L., & Hegele, R. A. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32802e6c12 · Cited by 22
Self-citation
The Role of Lipin 1 in Adipogenesis and Lipid Metabolism
Reue, K. (2007) · Novartis Foundation symposium · doi:10.1002/9780470985571.ch6 · Cited by 21
Genetic determinants of plasma lipoproteins
Pollex, R. L., & Hegele, R. A. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1005 · Cited by 16
Self-citation
What can the genome tell us about LDL cholesterol?
Krauss, R. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60213-5 · Cited by 12
Pharmacogenetics of lipid diseases
Ordovás, J. M. (2004) · Human Genomics · doi:10.1186/1479-7364-1-2-111 · Cited by 11

Flagged first, then by citations

Sorted by citations

Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants
Pierce, B. L., Ahsan, H., & VanderWeele, T. J. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq151 · Cited by 1,848
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Richardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003062 · Cited by 843
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635
Self-citation
Familial hypercholesterolaemia
Defesche, J. C., Gidding, S. S., Harada-Shiba, M., Hegele, R. A., Santos, R. D., & Wierzbicki, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.93 · Cited by 453
Self-citation

See all 472

Authors: Hegele, R. A.
Affiliations: Western University (CA)
Corresponding author: Hegele, Robert A.
ORCID: Hegele, Robert A.
Venue: Nature Reviews Genetics
Publisher: Springer Science and Business Media LLC
Published: 2009-02
Volume: 10
Issue: 2
Pages: 109-121
ISSN: 1471-0056 (ISSN-L)
1471-0064
DOI: 10.1038/nrg2481
OpenAlex: W2068700927
Cited by: 462
References: 107
Citations by year: 2026: 10 · 2025: 11 · 2024: 19 · 2023: 21 · 2022: 32 · 2021: 22 · 2020: 24 · 2019: 19 · 2018: 27 · 2017: 19 · 2016: 31 · 2015: 33 · 2014: 36 · 2013: 26 · 2012: 31
FWCI: 7.03
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Genetics (publishedVersion)
PubMed (publishedVersion)
Scholarship@Western (Western University) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: serum lipoproteins, plasma lipids, genetic architecture, cardiovascular risk, dyslipidemia, genome-wide association study, rare variants, lipid metabolism, metabolic networks, phenomics, resequencing, disease diagnosis and treatment
MeSH terms: Animals, Cholesterol, Humans, Hyperlipoproteinemias, Lipoproteins, Models, Biological, Triglycerides, Genomics, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma lipoproteins: genetic influences and clinical implications

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks